| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/11/2007 | US20070009525 Human Endokine Alpha and Methods of Use |
| 01/11/2007 | US20070009524 Methods of treating inflammation associated with viral infection with anti-tnf antibodies |
| 01/11/2007 | US20070009522 administering to an Rh-negative individual in need of an anti-Rh(D) monoclonal antibody, wherein monoclonal antibody exhibits a Fc gamma RTIII-type ADCC ( antibody-dependent cell-mediated cytotoxicity (ADCC) assays) level greater than 80% relative to a reference polyclonal anti-Rh(D) human antibody |
| 01/11/2007 | US20070009521 Human tumor necrosis factor TR21 and methods based thereon |
| 01/11/2007 | US20070009520 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 01/11/2007 | US20070009519 Immunoregulatory Antibodies and Uses Thereof |
| 01/11/2007 | US20070009517 Method of inducing immune tolerance |
| 01/11/2007 | US20070009516 Immune response-associated proteins |
| 01/11/2007 | US20070009515 Inflammatory skin disease-related slurp-2 gene and utilization thereof |
| 01/11/2007 | US20070009514 Prostaglandin receptor ep1 |
| 01/11/2007 | US20070009512 Recombinant bivalent monospecific immunoglobulin having at least two variable fragments of heavy chains of an immunoglobulin devoid of light chains |
| 01/11/2007 | US20070009510 Monoclonal antibodies against ricin toxin and methods of making and using thereof |
| 01/11/2007 | US20070009509 Antibody against nox1 polypeptide, method of diagnosing cancer with the use of nox1 gene and method of screening cancer growth inhibitor |
| 01/11/2007 | US20070009508 untagged antigen is used in conjunction with a polyclonal antibody to isolate cells recognizing the antigen; for cancers, autoimmune or inflammatory disorders |
| 01/11/2007 | US20070009488 Feline granulocyte macrophage colony stimulating factor nucleic acid molecules |
| 01/11/2007 | US20070009469 Treatment of skin, and wound repair, with thymosin beta 4 |
| 01/11/2007 | US20070009436 Radionuclide nanoparticles encased by inorganic shell having vector biomolecules attached thereto |
| 01/11/2007 | US20070009434 Imaging and therapeutic method using monocytes |
| 01/11/2007 | US20070009433 14094, a novel human trypsin family member and uses thereof |
| 01/11/2007 | DE202006007499U1 Verwendung einer Zusammensetzung, die Plexin-A1-DAP12-Interaktion inhibiert, zur Behandlung von Entzündungs-, Autoimmun- oder Knochenresorptionserkrankungen Use of a composition, the Plexin-A1-DAP12 interaction inhibited for the treatment of inflammatory, autoimmune or bone resorption |
| 01/11/2007 | CA2848662A1 Il-12/p40 binding proteins |
| 01/11/2007 | CA2655511A1 Methods of isolating cells and generating monoclonal antibodies |
| 01/11/2007 | CA2617539A1 Phosphospecific chemokine receptor antibodies |
| 01/11/2007 | CA2614145A1 Nucleic acid capable of binding to immunoglobulin g and use thereof |
| 01/11/2007 | CA2614076A1 Humanised antibodies specific for nogo-a and pharmaceutical uses thereof |
| 01/11/2007 | CA2613818A1 Anti-il-23 antibodies, compositions, methods and uses |
| 01/11/2007 | CA2613813A1 Protein preparation containing s1-5 |
| 01/11/2007 | CA2613749A1 Methods and compositions for diagnosis and treatment of viral and bacterial infections |
| 01/11/2007 | CA2612241A1 Human monoclonal antibodies to programmed death ligand 1 (pd-l1) |
| 01/11/2007 | CA2612239A1 Il-12/p40 binding proteins |
| 01/10/2007 | EP1742059A1 Use of PTA peptides for stratification of individuals having cancer |
| 01/10/2007 | EP1741789A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 01/10/2007 | EP1741785A1 Porcine circoviruses, nucleic acids, polypeptides and vaccines |
| 01/10/2007 | EP1741784A1 85kDa neisserial antigen |
| 01/10/2007 | EP1741783A1 Human antiamyloid beta peptide antibody and antibody fragment thereof |
| 01/10/2007 | EP1741779A2 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine mediated toxicity |
| 01/10/2007 | EP1741722A2 Polymorphisms in the human P2X7 gene |
| 01/10/2007 | EP1741449A1 Preventive and/or remedy for cancer |
| 01/10/2007 | EP1740954A1 Mass spectrometry of antibody conjugates |
| 01/10/2007 | EP1740946A2 Human monoclonal antibodies against cd20 |
| 01/10/2007 | EP1740619A1 Compositions and methods for treating proliferative disorders such as nk-type ldgl |
| 01/10/2007 | EP1740618A1 Compositions and methods for enhancing nk cell activity |
| 01/10/2007 | EP1740617A1 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo |
| 01/10/2007 | EP1740616A1 Anti-tfr antibody. |
| 01/10/2007 | EP1740615A2 Humanized anti-tgf-beta antibodies |
| 01/10/2007 | EP1740605A2 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 01/10/2007 | EP1740602A2 A peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5 |
| 01/10/2007 | EP1740224A2 Compositions as adjuvants to improve immune responses to vaccines and methods of use |
| 01/10/2007 | EP1740221A2 Methods and compositions for the treatment of polycystic diseases |
| 01/10/2007 | EP1740216A2 Antibody calicheamicin conjugates |
| 01/10/2007 | EP1740210A2 Irta-5 antibodies and their uses |
| 01/10/2007 | EP1740209A2 Method and system to remove soluble tnfr1, tnfr2, and il2 in patients |
| 01/10/2007 | EP1740208A2 Monoclonal antibodies specific for human ox40l (cd134l) |
| 01/10/2007 | EP1740206A2 Phep, an amino acid permease of staphylococcus aureus |
| 01/10/2007 | EP1740167A2 Treatment of type 1 diabetes with inhibitors of macrophage migration inhibitory factor |
| 01/10/2007 | EP1485129B1 Nanostructures containing pilin protein |
| 01/10/2007 | EP1417227B1 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/10/2007 | EP1113777B1 Novel hepatitis c virus peptides and uses thereof |
| 01/10/2007 | EP1078060B1 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 01/10/2007 | EP1035856B1 Isolated dna encoding human h3 histamine receptor |
| 01/10/2007 | EP1017723B1 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
| 01/10/2007 | EP0918796B1 Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein |
| 01/10/2007 | EP0911393B1 Peptide having cortistatin or somatostatin activity, process for the production of the same, and use of the same |
| 01/10/2007 | EP0812357B1 A method for making heteromultimeric polypeptides |
| 01/10/2007 | CN1894695A Altered antibodies having improved antigen-binding affinity |
| 01/10/2007 | CN1894409A Human LXR alpha variants |
| 01/10/2007 | CN1894408A Metabolic protein for weed-control agent, its gene, and its use |
| 01/10/2007 | CN1894406A Antibody composition-producing cell |
| 01/10/2007 | CN1894278A Akt activity specifically inhibiting polypeptide |
| 01/10/2007 | CN1894275A Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
| 01/10/2007 | CN1893979A Remedy for angitis |
| 01/10/2007 | CN1893975A Medicament comprising inhibitors of long pentraxin ptx3 |
| 01/10/2007 | CN1893966A Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 01/10/2007 | CN1891826A Gene specifically expressed in postmitotic dopaminergic neuron precursor cells |
| 01/10/2007 | CN1891825A Gene and protein relating to hepatocellular carcinoma |
| 01/10/2007 | CN1891716A No mitogen activity anti CD3 small molecular antibody designing method |
| 01/10/2007 | CN1891715A Inhibition of viral infection using monovalent antigen-binding proteins |
| 01/10/2007 | CN1891714A Ligand for herpes simplex virus entry mediator and methods of use |
| 01/10/2007 | CN1294418C Method and reagent box for inspecting mycelian protein antibody of white candida |
| 01/10/2007 | CN1294263C Heavy chain and light chain variable region gene of human B lymphocyte stimulation factor monoclonal antibody and its application |
| 01/10/2007 | CN1294148C Single-stranded cyctic trispecific antibody |
| 01/10/2007 | CN1294147C Combined process for producing animal blood fibronectin |
| 01/10/2007 | CN1294143C Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 01/09/2007 | US7161314 Motor control apparatus having current supply phase correction |
| 01/09/2007 | US7161031 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 01/09/2007 | US7160995 DNA encoding anti-TNF antibodies and peptides |
| 01/09/2007 | US7160993 Nucleic acids encoding PRO4400 polypeptides |
| 01/09/2007 | US7160990 Immunoglobulin for use in detection and prevention staphylococcus infections |
| 01/09/2007 | US7160989 Phosphorylation site specific serine and androgen receptors |
| 01/09/2007 | US7160987 Administering a monoclonal antibodie, that bind specifically to one or more preselected CD45R leukocyte antigens, including CD45RB epitope for prevention or reversal of transplant rejection or therapy of autoimmune diseases |
| 01/09/2007 | US7160985 For therapy of diabetes |
| 01/09/2007 | US7160869 Biologically active metal-containing nucleic acids |
| 01/09/2007 | US7160864 Methods for production of growth-promoting proteins and peptides for kidney epithelial cells |
| 01/09/2007 | US7160858 induce apoptosis in endothetial cells; binding to annexins; anticancer agents, vuision defects, rheumatic diseases , antidiabetic agents |
| 01/09/2007 | US7160722 Master bone formation transcription factor: compositions and methods of use |
| 01/09/2007 | US7160692 Detecting DNA damage by identifying the activation state of Ataxia Telangiectasia-Mutated kinase by determining the phosphorylation state of a specific serine residue |
| 01/09/2007 | US7160686 Immunizing a rat with a suspension of fetal cells from the same genetic line, recovering spleen cells, separating lymphocytes, immunizing a second time with the lymphocyte suspension, recovering the antiserum, adding kidney, lung and liver cells, filtration; immunoassay |
| 01/09/2007 | US7160549 including siderophore receptor polypeptides and porins from gram negative microbes, and preferably, lipopolysaccarhide at a concentration of no greater than about 10.0 endotoxin units per milliliter |
| 01/09/2007 | US7160547 Comprising a pharmaceutically acceptable carrier and a peptide immunogen for eliciting an immune response in a subject and having at least one streptolysin S epitope |
| 01/09/2007 | US7160543 Tumor necrosis factor nucleic acid; antiinflammatory agents, autoimmune disease, viricides, parasiticides, central nervous system disorders; anti-TNF peptides inhibit and/or neutralize epitopes of human tumor necrosis factor-alpha |